logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9861601 B1

PDFFull Text
Date of Patent:
Jan. 09, 2018

Filed:

Nov. 30, 2015

Treatment of pulmonary arterial hypertension with leukotriene inhibitors

Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Mark R. Nicolls, Palo Alto, CA (US);

Wen Tian, Mountain View, CA (US);

Jayakumar Rajadas, Cupertino, CA (US);

Assignee:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CT (US);

Attorneys:

Pamela J. Sherwood

Bozicevic, Field & Francis LLP

Primary Examiner:

Bethany P Barham

Assistant Examiner:

Barbara S Frazier

Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 9/00 (2006.01); A61K 31/428 (2006.01); A61K 31/216 (2006.01); A61K 31/222 (2006.01); A61K 45/06 (2006.01); A61K 31/197 (2006.01); A61K 31/40 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 9/007 (2013.01); A61K 9/0053 (2013.01); A61K 31/197 (2013.01); A61K 31/216 (2013.01); A61K 31/222 (2013.01); A61K 31/40 (2013.01); A61K 31/428 (2013.01); A61K 45/06 (2013.01);
Abstract

Pulmonary arterial hypertension (PAH) can be prevented in persons susceptible to the diseases and PAH patients can be treated by administering an effective dose of a leukotriene inhibitor. Suitable inhibitors include leukotriene Ahydrolase (LTAH) inhibitors, leukotriene Breceptor (BLT1/BLT2) antagonists, 5-lipoxygenase (5-LO) inhibitors, and 5-lipoxgygenase activating protein (FLAP) inhibitors.

Find Patent Forward Citations

Nicolls, Mark. (2018). Treatment of pulmonary arterial hypertension with leukotriene inhibitors (U.S. Patent No. 9861601). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9861601

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…